| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,584 |
3,741 |
$261K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,919 |
2,739 |
$141K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
8,807 |
5,419 |
$95K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,129 |
1,809 |
$87K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15,507 |
6,150 |
$87K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,207 |
1,285 |
$49K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,618 |
5,655 |
$48K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,448 |
697 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,902 |
881 |
$6K |
| 96127 |
|
3,526 |
2,308 |
$5K |
| 87807 |
|
485 |
302 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
658 |
302 |
$371.78 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
828 |
398 |
$291.35 |
| 81003 |
|
32 |
27 |
$27.60 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
42 |
12 |
$17.92 |
| 3351F |
|
379 |
313 |
$0.00 |
| 3725F |
|
969 |
737 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
248 |
225 |
$0.00 |